Action Avalon GloboCare - AVCO

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,5259

Prix Achat

0,52

Prix Vente

0,5521

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

0,5259

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”

Company to Begin Trading under New Symbol “ALBT” on November 10, 2022 Symbol Change Better Reflects Avalon’s...

Avalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 Million

Company to acquire a majority interest in Laboratory Services MSO, LLC, a leading reference laboratory with...

Avalon GloboCare Receives Allowance for Joint U.S. Patent

FREEHOLD, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global...

Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society

Findings support utility of QTY protein code as a novel platform to generate water-soluble proteins for wide...

Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

FREEHOLD, N.J., May 25, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global...

Avalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular Therapy

Goal of Partnership is to expand Avalon’s R&D pipeline to include innovative companion diagnostics in...

Avalon GloboCare Expands IP Portfolio; Files 16 New Patent Applications

Co-inventors are leading international universities and cellular therapy developers Patent applications cover...

Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies

Leveraging Avalon’s existing Flash-CARTM technology platform to develop next-generation mRNA-based CAR-NK...

Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs

Company continues to expand and accelerate its R&D strategies for high-impact translational and clinical...

Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market

FREEHOLD, N.J., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

AVCO - Frequently Asked Questions (FAQ)

What is the current Avalon GloboCare share price?

The current share price of Avalon GloboCare is US$ 0,5259

What is the 1 year trading range for Avalon GloboCare share price?

Avalon GloboCare has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
AIEVThunder Power Holdings Inc	US$ 0,3508 (53,25%)	2,12M
AREBAmerican Rebel Holdings Inc	US$ 0,4486 (47,61%)	22,59M
TOIOncology Institute Inc	US$ 0,903 (43,11%)	2
HFBLHome Federal Bancorp Inc of Louisiana	US$ 17,99 (42,38%)	1
CSPICSP Inc	US$ 22,00 (41,94%)	16
RVYLRYVYL Inc	US$ 0,4001 (-54,43%)	2
HEPAHepion Pharmaceuticals Inc	US$ 0,05 (-40,48%)	8,4M
ZYXIZynex Inc	US$ 4,60 (-34,29%)	19,02k
SYRSSyros Pharmaceuticals Inc	US$ 0,0925 (-31,99%)	1,94M
SERASera Prognostics Inc	US$ 3,01 (-28,67%)	4
STISolidion Technology Inc	US$ 0,1595 (26,49%)	77,32M
AREBAmerican Rebel Holdings Inc	US$ 0,4486 (47,61%)	22,59M
HCTIHealthcare Triangle Inc	US$ 0,4464 (37,35%)	11,13M
HEPAHepion Pharmaceuticals Inc	US$ 0,05 (-40,48%)	8,4M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8,37 (5,82%)	8,12M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Avalon GloboCare Corporation (AVCO)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

AVCO Dernières nouvelles

Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”

Avalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 Million

Avalon GloboCare Receives Allowance for Joint U.S. Patent

Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society

Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

Avalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular Therapy

Avalon GloboCare Expands IP Portfolio; Files 16 New Patent Applications

Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies

Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs

Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market

AVCO - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Avalon GloboCare Corporation (AVCO) Cours

Avalon GloboCare Corporation (AVCO)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

AVCO Dernières nouvelles

Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”

Avalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 Million

Avalon GloboCare Receives Allowance for Joint U.S. Patent

Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society

Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

Avalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular Therapy

Avalon GloboCare Expands IP Portfolio; Files 16 New Patent Applications

Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies

Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs

Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market

AVCO - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS